In Vitro Mineralisation of Tissue-Engineered Cartilage Reduces Endothelial Cell Migration, Proliferation and Tube Formation

Cells. 2023 Apr 20;12(8):1202. doi: 10.3390/cells12081202.

Abstract

Tissue engineering bone via endochondral ossification requires the generation of a cartilage template which undergoes vascularisation and remodelling. While this is a promising route for bone repair, achieving effective cartilage vascularisation remains a challenge. Here, we investigated how mineralisation of tissue-engineered cartilage affects its pro-angiogenic potential. To generate in vitro mineralised cartilage, human mesenchymal stromal cell (hMSC)-derived chondrogenic pellets were treated with β-glycerophosphate (BGP). After optimising this approach, we characterised the changes in matrix components and pro-angiogenic factors by gene expression analysis, histology and ELISA. Human umbilical vein endothelial cells (HUVECs) were exposed to pellet-derived conditioned media, and migration, proliferation and tube formation were assessed. We established a reliable strategy to induce in vitro cartilage mineralisation, whereby hMSC pellets are chondrogenically primed with TGF-β for 2 weeks and BGP is added from week 2 of culture. Cartilage mineralisation determines loss of glycosaminoglycans, reduced expression but not protein abundance of collagen II and X, and decreased VEGFA production. Finally, the conditioned medium from mineralised pellets showed a reduced ability to stimulate endothelial cell migration, proliferation and tube formation. The pro-angiogenic potential of transient cartilage is thus stage-dependent, and this aspect must be carefully considered in the design of bone tissue engineering strategies.

Keywords: angiogenesis; bone tissue engineering; endochondral ossification; mesenchymal stromal cells; mineralisation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcification, Physiologic
  • Cartilage* / metabolism
  • Cell Proliferation
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Tissue Engineering* / methods

Grants and funding

The project was supported by the following funding: the European Union Horizon 2020 Research and Innovation Program under grant agreement 801159; the Dutch Research Council (NWO)-XS Science grant OCENW.XS5.074; Erasmus MC-Health~Holland TKI-LSH grant EMCLSH20022. E.J. is supported by the China Scholarship Council (CSC, NO. 202207720011) and Wenzhou Wangqiao Orthopedic Hospital.